Ecolab Continues Mission to Protect What's Vital With Deep Investment in Life Sciences

Ecolab's acquisition of Purolite in 2021,1 expanded Ecolab's reach directly into the drug manufacturing process. Since acquisition, Ecolab has invested its efforts into developing innovations such as its revolutionary affinity protein A resin, DurA CycleTM, in partnership with Repligen Cor...

Full description

Saved in:
Bibliographic Details
Published inBiopharm International Vol. 37; no. 8; pp. 23 - 26
Main Authors Beck, Christophe, Crowe, Hayley, Paluri, Srini
Format Trade Publication Article
LanguageEnglish
Published Monmouth Junction MultiMedia Healthcare Inc 01.09.2024
Subjects
Chromatography
Costs
Customers
Drug development
Efficiency
Innovations
Life sciences
Life span
Manufacturing
Pharmaceutical industry
Proteins
Resins
Supply chains
Technological change
Online AccessGet full text

Cover

More Information
Summary:Ecolab's acquisition of Purolite in 2021,1 expanded Ecolab's reach directly into the drug manufacturing process. Since acquisition, Ecolab has invested its efforts into developing innovations such as its revolutionary affinity protein A resin, DurA CycleTM, in partnership with Repligen Corporation, to support large-scale biomanufacturing. [...]we just celebrated a relationship with a specific customer who we have supported for 70 years. "The value that we provide to biopharmaceutical companies is highly tied to performance and quality," says Senior Vice President and General Manager with Ecolab, Srini Paluri. ADAPTING TO AN EVOLVING PIPELINE Changes to the drug development pipeline have presented [the industry] with unique challenges in bioprocessing, explains Hayley Crowe, Executive Vice President and General Manager of the Life Sciences sector. DurA Cycle enhances this process by enabling multiple manufacturing cycles without significant loss of resin efficacy, thereby extending the lifespan of the resins and reducing overall operational costs. "Because you are producing higher yield, you can run less cycles.
ISSN:1542-166X
1939-1862